120 related articles for article (PubMed ID: 12576284)
1. Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.
Tsoukalas C; Pirmettis I; Patsis G; Pelecanou M; Bodo K; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
J Inorg Biochem; 2003 Jan; 93(3-4):213-20. PubMed ID: 12576284
[TBL] [Abstract][Full Text] [Related]
2. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.
Papachristou M; Pirmettis IC; Tsoukalas C; Papagiannopoulou D; Raptopoulou C; Terzis A; Stassinopoulou CI; Chiotellis E; Pelecanou M; Papadopoulos M
Inorg Chem; 2003 Sep; 42(18):5778-84. PubMed ID: 12950229
[TBL] [Abstract][Full Text] [Related]
4. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
Bouziotis P; Pirmettis I; Pelecanou M; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
Chemistry; 2001 Sep; 7(17):3671-80. PubMed ID: 11575768
[TBL] [Abstract][Full Text] [Related]
5. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
6. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.
León A; Rey A; Mallo L; Pirmettis I; Papadopoulos M; León E; Pagano M; Manta E; Incerti M; Raptopoulou C; Terzis A; Chiotellis E
Nucl Med Biol; 2002 Feb; 29(2):217-26. PubMed ID: 11823127
[TBL] [Abstract][Full Text] [Related]
7. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Tsoukalas Ch; Nikoladou L; Drossopoulou G; Dalla C; Pelecanou M; Papadopoulou-Daifotis Z; Papadopoulos M; Chiotellis E
Nucl Med Biol; 2002 Nov; 29(8):825-32. PubMed ID: 12453592
[TBL] [Abstract][Full Text] [Related]
8. Rhenium(V) and technetium(V) nitrido complexes with mixed tridentate π-donor and monodentate π-acceptor ligands.
Boschi A; Cazzola E; Uccelli L; Pasquali M; Ferretti V; Bertolasi V; Duatti A
Inorg Chem; 2012 Mar; 51(5):3130-7. PubMed ID: 22324784
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and biological evaluation of technetium(III) complexes with tridentate/bidentate S,E,S/P,S coordination (E = O, N(CH(3)), S): a novel approach to robust technetium chelates suitable for linking the metal to biomolecules.
Pietzsch HJ; Seifert S; Syhre R; Tisato F; Refosco F; Leibnitz P; Spies H
Bioconjug Chem; 2003; 14(1):136-43. PubMed ID: 12526702
[TBL] [Abstract][Full Text] [Related]
11. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of novel 99gTc(V) and Re(V) complexes with water-soluble tetraaza diamido dipyridino ligands: single-crystal X-ray structural investigations of mono- and dinuclear complexes.
Kurti L; Papagiannopoulou D; Papadopoulos M; Pirmettis I; Raptopoulou CP; Terzis A; Chiotellis E; Harmata M; Kuntz RR; Pandurangi RS
Inorg Chem; 2003 May; 42(9):2960-7. PubMed ID: 12716188
[TBL] [Abstract][Full Text] [Related]
13. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: structure-affinity considerations.
Johannsen B; Scheunemann M; Spies H; Brust P; Wober J; Syhre R; Pietzsch HJ
Nucl Med Biol; 1996 May; 23(4):429-38. PubMed ID: 8832697
[TBL] [Abstract][Full Text] [Related]
14. A novel technetium-99m radioligand for the 5-HT(1A) receptor derived from desmethyl-WAY-100635 (DWAY).
Heimbold I; Drews A; Syhre R; Kretzschmar M; Pietzsch HJ; Johannsen B
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):82-7. PubMed ID: 11807611
[TBL] [Abstract][Full Text] [Related]
15. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
Mastrostamatis SG; Papadopoulos MS; Pirmettis IC; Paschali E; Varvarigou AD; Stassinopoulou CI; Raptopoulou CP; Terzis A; Chiotellis E
J Med Chem; 1994 Sep; 37(20):3212-8. PubMed ID: 7932548
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of oxorhenium(V) complexes with diamido amine ancillary ligands and their role in oxygen atom transfer catalysis.
Feng Y; Aponte J; Houseworth PJ; Boyle PD; Ison EA
Inorg Chem; 2009 Dec; 48(23):11058-66. PubMed ID: 19888748
[TBL] [Abstract][Full Text] [Related]
17. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.
Friebe M; Mahmood A; Bolzati C; Drews A; Johannsen B; Eisenhut M; Kraemer D; Davison A; Jones AG
J Med Chem; 2001 Sep; 44(19):3132-40. PubMed ID: 11543682
[TBL] [Abstract][Full Text] [Related]
18. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
19. A New Donor Atom System [(SNN)(S)] for the Synthesis of Neutral Oxotechnetium(V) Mixed-Ligand Complexes.
Papadopoulos MS; Pelecanou M; Pirmettis IC; Spyriounis DM; Raptopoulou CP; Terzis A; Stassinopoulou CI; Chiotellis E
Inorg Chem; 1996 Jul; 35(15):4478-4483. PubMed ID: 11666668
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Oxorhenium(V) and Oxotechnetium(V) Complexes That Bind to Amyloid-β Plaques.
Hayne DJ; White JM; McLean CA; Villemagne VL; Barnham KJ; Donnelly PS
Inorg Chem; 2016 Aug; 55(16):7944-53. PubMed ID: 27459001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
